Compare Injective (INJ) vs Metis (METIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Metis — how do they compare? Injective trades at Rp76,055 (market cap Rp7,62T, Rp1,22T 24h volume), while Metis trades at Rp42,395 (market cap Rp326,65M, Rp22,61M 24h volume). The key difference: Injective is far larger — about 23327.7× Metis's market cap, and Metis's supply is capped (7,7M / 10M METIS (78%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Metis for 77 Days on average.
| INJ | METIS | |
|---|---|---|
Market Cap | Rp7,62T | Rp326,65M |
Volume (24h) | Rp1,22T | Rp22,61M |
Circulating Supply | 100M INJ | 7,7M / 10M METIS (78%) |
Typical Hold Time | 37 Days | 77 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Metis is currently trading at Rp42,985 with a bearish technical signal, showing weak momentum below key resistance levels. The token faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. With 78% of the 10 million max supply in circulation and an average hold time of 77 days, the asset shows moderate distribution stability. Recent ecosystem developments include ongoing protocol upgrades to enhance Layer 2 scalability and reduce transaction costs.
Overall outlook remains cautious with technical weakness dominating. Key opportunities lie in potential Layer 2 adoption growth, while major risks include continued bearish momentum and crypto market volatility. Investors should monitor support at Rp41,711 for potential breakdown scenarios.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Metis
Metis is an Ethereum Layer-2 scaling solution aiming to solve the blockchain trilemma: that blockchains cannot be decentralized, secure, and scalable simultaneously. It also strives to solve Ethereum's biggest challenges: speed, cost and scalability.
Read more on METIS →
